Logo image of OM

OUTSET MEDICAL INC (OM) Stock Fundamental Analysis

NASDAQ:OM - Nasdaq - US6901452069 - Common Stock - Currency: USD

17.51  +0.09 (+0.52%)

After market: 17.51 0 (0%)

Fundamental Rating

2

OM gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 187 industry peers in the Health Care Equipment & Supplies industry. OM may be in some trouble as it scores bad on both profitability and health. OM is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year OM has reported negative net income.
In the past year OM has reported a negative cash flow from operations.
OM had negative earnings in each of the past 5 years.
In the past 5 years OM always reported negative operating cash flow.
OM Yearly Net Income VS EBIT VS OCF VS FCFOM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 -50M -100M -150M

1.2 Ratios

With a Return On Assets value of -37.79%, OM is not doing good in the industry: 62.03% of the companies in the same industry are doing better.
OM has a Return On Equity (-67.00%) which is in line with its industry peers.
Industry RankSector Rank
ROA -37.79%
ROE -67%
ROIC N/A
ROA(3y)-47.4%
ROA(5y)-38.06%
ROE(3y)-228.02%
ROE(5y)-148.69%
ROIC(3y)N/A
ROIC(5y)N/A
OM Yearly ROA, ROE, ROICOM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 -100 -200 -300 -400

1.3 Margins

With a Gross Margin value of 35.93%, OM is not doing good in the industry: 68.98% of the companies in the same industry are doing better.
OM's Gross Margin has improved in the last couple of years.
OM does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 35.93%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y66.06%
GM growth 5YN/A
OM Yearly Profit, Operating, Gross MarginsOM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 -1K -2K -3K

More info and screens

3

2. Health

2.1 Basic Checks

OM does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for OM has been increased compared to 1 year ago.
Compared to 5 years ago, OM has more shares outstanding
Compared to 1 year ago, OM has a worse debt to assets ratio.
OM Yearly Shares OutstandingOM Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
OM Yearly Total Debt VS Total AssetsOM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

OM has an Altman-Z score of -3.40. This is a bad value and indicates that OM is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of OM (-3.40) is worse than 68.45% of its industry peers.
A Debt/Equity ratio of 0.55 indicates that OM is somewhat dependend on debt financing.
OM has a worse Debt to Equity ratio (0.55) than 65.24% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.55
Debt/FCF N/A
Altman-Z -3.4
ROIC/WACCN/A
WACC7.31%
OM Yearly LT Debt VS Equity VS FCFOM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M

2.3 Liquidity

A Current Ratio of 8.37 indicates that OM has no problem at all paying its short term obligations.
OM's Current ratio of 8.37 is amongst the best of the industry. OM outperforms 88.77% of its industry peers.
OM has a Quick Ratio of 6.74. This indicates that OM is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of OM (6.74) is better than 87.70% of its industry peers.
Industry RankSector Rank
Current Ratio 8.37
Quick Ratio 6.74
OM Yearly Current Assets VS Current LiabilitesOM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

5

3. Growth

3.1 Past

OM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 47.80%, which is quite impressive.
OM shows a decrease in Revenue. In the last year, the revenue decreased by -7.84%.
Measured over the past years, OM shows a very strong growth in Revenue. The Revenue has been growing by 49.74% on average per year.
EPS 1Y (TTM)47.8%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%62.11%
Revenue 1Y (TTM)-7.84%
Revenue growth 3Y3.48%
Revenue growth 5Y49.74%
Sales Q2Q%5.62%

3.2 Future

Based on estimates for the next years, OM will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.88% on average per year.
The Revenue is expected to grow by 13.25% on average over the next years. This is quite good.
EPS Next Y80.28%
EPS Next 2Y36.15%
EPS Next 3Y22.97%
EPS Next 5Y14.88%
Revenue Next Year8.54%
Revenue Next 2Y10.25%
Revenue Next 3Y10.58%
Revenue Next 5Y13.25%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
OM Yearly Revenue VS EstimatesOM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 50M 100M 150M 200M
OM Yearly EPS VS EstimatesOM Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -20 -40 -60 -80

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

OM reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for OM. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
OM Price Earnings VS Forward Price EarningsOM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OM Per share dataOM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -10 -20

4.3 Compensation for Growth

OM's earnings are expected to grow with 22.97% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y36.15%
EPS Next 3Y22.97%

More info and screens

0

5. Dividend

5.1 Amount

OM does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

OUTSET MEDICAL INC

NASDAQ:OM (7/21/2025, 8:00:02 PM)

After market: 17.51 0 (0%)

17.51

+0.09 (+0.52%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)05-07 2025-05-07/amc
Earnings (Next)08-05 2025-08-05/amc
Inst Owners78.57%
Inst Owner Change0%
Ins Owners0.44%
Ins Owner Change99.18%
Market Cap310.28M
Analysts83.08
Price Target27.03 (54.37%)
Short Float %13.94%
Short Ratio6.25
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-109.98%
Min EPS beat(2)-232.87%
Max EPS beat(2)12.92%
EPS beat(4)2
Avg EPS beat(4)-52.69%
Min EPS beat(4)-232.87%
Max EPS beat(4)12.92%
EPS beat(8)3
Avg EPS beat(8)-27.85%
EPS beat(12)4
Avg EPS beat(12)-22.29%
EPS beat(16)6
Avg EPS beat(16)-16.31%
Revenue beat(2)2
Avg Revenue beat(2)2.17%
Min Revenue beat(2)0.47%
Max Revenue beat(2)3.86%
Revenue beat(4)3
Avg Revenue beat(4)-1.74%
Min Revenue beat(4)-14.74%
Max Revenue beat(4)3.86%
Revenue beat(8)4
Avg Revenue beat(8)-2.73%
Revenue beat(12)7
Avg Revenue beat(12)-1.97%
Revenue beat(16)10
Avg Revenue beat(16)-1.05%
PT rev (1m)10.42%
PT rev (3m)-29.33%
EPS NQ rev (1m)2.72%
EPS NQ rev (3m)-23.85%
EPS NY rev (1m)0%
EPS NY rev (3m)-55.84%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.56%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.67%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.69
P/FCF N/A
P/OCF N/A
P/B 1.83
P/tB 1.83
EV/EBITDA N/A
EPS(TTM)-21.69
EYN/A
EPS(NY)-3.95
Fwd EYN/A
FCF(TTM)-5.46
FCFYN/A
OCF(TTM)-5.42
OCFYN/A
SpS6.51
BVpS9.59
TBVpS9.59
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -37.79%
ROE -67%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 35.93%
FCFM N/A
ROA(3y)-47.4%
ROA(5y)-38.06%
ROE(3y)-228.02%
ROE(5y)-148.69%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y66.06%
GM growth 5YN/A
F-Score6
Asset Turnover0.38
Health
Industry RankSector Rank
Debt/Equity 0.55
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 12.24%
Cap/Sales 0.59%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 8.37
Quick Ratio 6.74
Altman-Z -3.4
F-Score6
WACC7.31%
ROIC/WACCN/A
Cap/Depr(3y)78.75%
Cap/Depr(5y)116.96%
Cap/Sales(3y)3.55%
Cap/Sales(5y)6.39%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)47.8%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%62.11%
EPS Next Y80.28%
EPS Next 2Y36.15%
EPS Next 3Y22.97%
EPS Next 5Y14.88%
Revenue 1Y (TTM)-7.84%
Revenue growth 3Y3.48%
Revenue growth 5Y49.74%
Sales Q2Q%5.62%
Revenue Next Year8.54%
Revenue Next 2Y10.25%
Revenue Next 3Y10.58%
Revenue Next 5Y13.25%
EBIT growth 1Y43.1%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year45.7%
EBIT Next 3Y17.24%
EBIT Next 5Y16.17%
FCF growth 1Y39.47%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y36.87%
OCF growth 3YN/A
OCF growth 5YN/A